IS7996A - 4- (2-phenylsulfanyl-phenyl) -piperidine derivatives that inhibit serotonin reuptake - Google Patents

4- (2-phenylsulfanyl-phenyl) -piperidine derivatives that inhibit serotonin reuptake

Info

Publication number
IS7996A
IS7996A IS7996A IS7996A IS7996A IS 7996 A IS7996 A IS 7996A IS 7996 A IS7996 A IS 7996A IS 7996 A IS7996 A IS 7996A IS 7996 A IS7996 A IS 7996A
Authority
IS
Iceland
Prior art keywords
phenylsulfanyl
phenyl
serotonin reuptake
piperidine derivatives
inhibit serotonin
Prior art date
Application number
IS7996A
Other languages
Icelandic (is)
Other versions
IS2676B (en
Inventor
Püschl Ask
Bang-Andersen Benny
Jørgensen Morten
Ruhland Thomas
Bryan Stensbøl Tine
Original Assignee
H. Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36091716&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS7996(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2004/000244 external-priority patent/WO2004087156A1/en
Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S
Publication of IS7996A publication Critical patent/IS7996A/en
Publication of IS2676B publication Critical patent/IS2676B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/24—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS7996A 2003-04-04 2005-08-22 4- (2-phenylsulfanyl-phenyl) -piperidine derivatives that inhibit serotonin reuptake IS2676B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200300520 2003-04-04
PCT/DK2004/000244 WO2004087156A1 (en) 2003-04-04 2004-04-02 4-(2-phenylsulfanyl-phenyl)-piperidine derivatives as serotonin reuptake inhibitors

Publications (2)

Publication Number Publication Date
IS7996A true IS7996A (en) 2005-08-22
IS2676B IS2676B (en) 2010-09-15

Family

ID=36091716

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7996A IS2676B (en) 2003-04-04 2005-08-22 4- (2-phenylsulfanyl-phenyl) -piperidine derivatives that inhibit serotonin reuptake

Country Status (10)

Country Link
KR (1) KR101107536B1 (en)
CN (1) CN1780622A (en)
AR (1) AR043965A1 (en)
BR (1) BRPI0408647A (en)
CL (1) CL2004000725A1 (en)
EA (1) EA010869B1 (en)
IS (1) IS2676B (en)
NZ (1) NZ541859A (en)
UA (1) UA81472C2 (en)
ZA (1) ZA200507181B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200932225A (en) * 2007-12-14 2009-08-01 Lundbeck & Co As H 4-[2,3-difluoro-6-(2-fluoro-4-methyl-phenylsulfanyl)-phenyl]-piperidine
CN105348204B (en) * 2015-11-18 2018-09-14 乳源瑶族自治县大众药品贸易有限公司 1- heterocycles -2- (Heteroarylthio) benzene derivatives and its application method and purposes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4241071A (en) * 1977-01-27 1980-12-23 American Hoechst Corporation Antidepressant (α-phenyl-2-tolyl)azacycloalkanes
US4198419A (en) * 1979-01-10 1980-04-15 American Hoechst Corporation Phenylthiophenylpiperidines
GEP20043160B (en) * 1999-10-13 2004-01-26 Pfizer Products Inc Us Biaryl Ether Derivatives, Pharmaceutical Compositions Containing Them and Their Use as Monoamine Reuptake Inhibitors
UA81749C2 (en) * 2001-10-04 2008-02-11 Х. Луннбек А/С Derivated of phenylpiperazine as serotonin reuptake inhibitorS

Also Published As

Publication number Publication date
IS2676B (en) 2010-09-15
NZ541859A (en) 2008-10-31
AR043965A1 (en) 2005-08-17
UA81472C2 (en) 2008-01-10
EA200501577A1 (en) 2006-04-28
CL2004000725A1 (en) 2005-02-18
EA010869B1 (en) 2008-12-30
KR20050119681A (en) 2005-12-21
BRPI0408647A (en) 2006-03-07
KR101107536B1 (en) 2012-01-31
ZA200507181B (en) 2007-03-28
CN1780622A (en) 2006-05-31

Similar Documents

Publication Publication Date Title
IS2732B (en) Phenyl-piperidine derivatives as serotonin reuptake inhibitors
IS8136A (en) N-pyrrolidin-3-yl-amide derivatives that inhibit serotonin and norepinephrine reuptake
IS8189A (en) New replaced 3-sulfur indole
ATE479681T1 (en) SUBSTITUTED PIPERIDINES
IS7884A (en) Diazepinoindole derivatives that inhibit kinase
EP1720874A4 (en) 4-substituted piperidine derivatives
IS8152A (en) Phosphatidyllinositol inhibits 3-kinase
NO20054224D0 (en) New 2-pyridinecarboxamide derivatives
EE200300478A (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
DK1773810T3 (en) New 4-benzylidene piperidine derivatives
IS8007A (en) 4- (2-phenylsulfanyl-phenyl) -1,2,3,6-tetrahydropyridine derivatives which inhibit serotonin reuptake
EP1870401A4 (en) 1,4-substituted piperazine derivative
IS6704A (en) Phenoxybenzylamine derivatives which selectively inhibit serotonin reuptake
MA28801B1 (en) ANTIHISTAMINE COMPOSITION
NL2000937A1 (en) Piperidine derivatives.
IS6960A (en) Phenyl heterocyclyl ether derivatives as serotonin reuptake inhibitors
MA26329A1 (en) IMPROVED HANGER
DE602004004387D1 (en) HANGER
IS7901A (en) 4- (2-Phenyloxyphenyl) -piperidine or -1,2,3,6-tetrahydropyridine derivatives that inhibit serotonin reuptake
DK1656305T3 (en) New decor
SI1710240T1 (en) Piperazine derivatives and their use as serotonin reuptake inhibitors or as neurokinin antagonists
IS7996A (en) 4- (2-phenylsulfanyl-phenyl) -piperidine derivatives that inhibit serotonin reuptake
IS2815B (en) 2- (1H-indolylsulfanyl) -benzylamine derivatives as selective serotonin reuptake inhibitors (SSRIs).
ZA200509132B (en) N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
DK1377550T3 (en) Phenyl heterocyclylate derivatives as serotonin re-uptake inhibitors